Home/Filings/4/0001610717-25-000021
4//SEC Filing

Hata Yujiro S 4

Accession 0001610717-25-000021

CIK 0001676725other

Filed

Feb 18, 7:00 PM ET

Accepted

Feb 19, 6:00 AM ET

Size

6.6 KB

Accession

0001610717-25-000021

Insider Transaction Report

Form 4
Period: 2025-02-18
Hata Yujiro S
DirectorPresident and CEO
Transactions
  • Exercise/Conversion

    Common Stock

    2025-02-18$19.52/sh+12,808$250,012690,695 total
  • Exercise/Conversion

    Stock Option (right to buy)

    2025-02-1812,808182,192 total
    Exercise: $19.52Exp: 2031-02-23Common Stock (12,808 underlying)
Footnotes (1)
  • [F1]The shares subject to the option are fully vested and exercisable.

Documents

1 file

Issuer

IDEAYA Biosciences, Inc.

CIK 0001676725

Entity typeother

Related Parties

1
  • filerCIK 0001649119

Filing Metadata

Form type
4
Filed
Feb 18, 7:00 PM ET
Accepted
Feb 19, 6:00 AM ET
Size
6.6 KB